www.fdanews.com/articles/183821-cardiofocus-receives-ce-mark-for-heartlight-excalibur-balloon
CardioFocus Receives CE Mark for HeartLight Excalibur Balloon
October 5, 2017
Cardio Focus received a CE Mark for its HeartLight Excalibur Balloon for treatment of atrial fibrillation.
The device is based on the company's FDA-approved HeartLight endoscopic ablation system and includes advanced features to optimize tissue contact during pulmonary vein isolation procedures.
The device provides a treatment option for AF patients whose heart arrhythmias are insufficiently controlled with medication.